Preliminary evidence for the dedifferentiation of RAW 264.7 cells into mesenchymal progenitor-like cells by a purine analog

Tissue Engineering - Part A

Volumn 18, Issue 17-18, 2012, Pages 1890-1901

  Qu, Guowei ^a   Von Schroeder, Herbert P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; MOLECULAR WEIGHT; OSTEOBLASTS; STEM CELLS;

ADIPOCYTES; ADIPOGENIC; C-JUN N-TERMINAL KINASE; CELL DEVELOPMENT; HEMATOPOIETIC CELL LINE; HUMAN BONES; IN-VITRO; MACROPHAGE CELL LINE; MESENCHYMAL STEM CELL; MINERALIZED NODULES; MULTIPOTENTIAL CELLS; MYOBLASTS; OSTEOBLAST MARKERS; OSTEOCALCIN; OSTEOGENIC; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; RAW CELLS; REGENERATIVE CAPACITY; REVERSE TRANSFORMATION;

SCAFFOLDS (BIOLOGY);

MURINAE;

2 (4 MORPHOLINOANILINO) 6 CYCLOHEXYLAMINOPURINE; 2-(4-MORPHOLINOANILINO)-6-CYCLOHEXYLAMINOPURINE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; CARBOCYANINE; CYANINE DYE 5; ENDOGLIN PROTEIN, MOUSE; MEMBRANE ANTIGEN; MORPHOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PURINE DERIVATIVE; SIGNAL PEPTIDE; STRESS ACTIVATED PROTEIN KINASE; STRO 1 ANTIGEN, MOUSE; STRO-1 ANTIGEN, MOUSE; TISSUE SCAFFOLD;

ADIPOGENESIS; ANIMAL; ARTICLE; BONE; CELL DEDIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MOUSE; RADIOGRAPHY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ADIPOGENESIS; ANIMALS; ANTHRACENES; ANTIGENS, SURFACE; BONE AND BONES; CARBOCYANINES; CELL DEDIFFERENTIATION; CELL LINE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, FLUORESCENCE; MORPHOLINES; PROTEIN KINASE INHIBITORS; PURINES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84866981533     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0692     Document Type: Article

References (58)

1. Dazzi, F., and Horwood, N.J. Potential of mesenchymal stem cell therapy. Curr Opin Oncol 19, 650, 2007.
2. Phinney, D.G., and Prockop, D.J. Concise review: mesen-chymal stem/multi-potent stromal cells (MSCs): the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25, 2896, 2007.
3. Brown, M.E., Rondon, E., Rajesh, D., Mack, A., Lewis, R., Feng, X., et al. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 5, e11373.
4. Maherali, N., and Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595, 2008.
5. Pufe, T., Petersen, W., Fandrich, F., Varoga, D., Wruck, C. J., Mentlein, R., et al. Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. J Orthop Res 26, 304, 2008.
6. Ungefroren, H., Groth, S., Hyder, A., Thomsen, N., Hinz, H., Reiling, N., et al. The generation of programmable cells of monocytic origin involves partial repression of monocyte/macrophage markers and reactivation of pluripotency genes. Stem Cells Dev 19, 1769, 2010.
7. Hu, G., Liu, P., Feng, J., Jin, Y. A novel population of mes-enchymal progenitors with hematopoietic potential originated from CD14 peripheral blood mononuclear cells. Int J Med Sci 8, 16, 2010.
8. Seta, N., and Kuwana, M. Derivation of multipotent progenitors from human circulating CD14+ monocytes. Exp Hematol 38, 557, 2010.
9. Mooney, J.E., Rolfe, B.E., Osborne, G.W., Sester, D.P., van Rooijen, N., Campbell, G.R., et al. Cellular plasticity of inflammatory myeloid cells in the peritoneal foreign body response. Am J Pathol 176, 369, 2010.
10. Zhang, Z., and Shively, J.E. Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PLoS One 5, e13985.
11. McGann, C.J., Odelberg, S.J., and Keating, M.T. Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci U S A 98, 13699, 2001.
12. Odelberg, S.J., Kollhoff, A., and Keating, M.T. Dedifferentiation of mammalian myotubes induced by msx1. Cell 103, 1099, 2000.
13. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861, 2007.
14. Tsai, R.Y., Kittappa, R., and McKay, R.D. Plasticity, niches, and the use of stem cells. Dev Cell 2, 707, 2002.
15. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917, 2007.
16. Ding, S., Gray, N.S., Wu, X., Ding, Q., and Schultz, P.G. A combinatorial scaffold approach toward kinase-directed heterocycle libraries. J Am Chem Soc 124, 1594, 2002.
17. Chen, S., Zhang, Q., Wu, X., Schultz, P.G., and Ding, S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126, 410, 2004.
18. Anastasia, L., Sampaolesi, M., Papini, N., Oleari, D., La-morte, G., Tringali, C., et al. Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell Death Differ 13, 2042, 2006.
19. Li, R., Zhu, S., He, X., and Xie, Z. Reversine inhibits spontaneous synaptic transmission in cultured rat hippocampal neurons. Cell Biol Int 31, 540, 2007.
20. Bruder, S.P., Horowitz, M.C., Mosca, J.D., and Haynes-worth, S.E. Monoclonal antibodies reactive with human os-teogenic cell surface antigens. Bone 21, 225, 1997.
21. Gronthos, S., Zannettino, A.C., Hay, S.J., Shi, S., Graves, S.E., Kortesidis, A., et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116, 1827, 2003.
22. Byers, R.J., Brown, J., Brandwood, C., Wood, P., Staley, W., Hainey, L., et al. Osteoblastic differentiation and mRNA analysis of STRO-1-positive human bone marrow stromal cells using primary in vitro culture and poly (A) PCR. J Pathol 187, 374, 1999.
23. Lee, W., McCulloch, C.A. Deregulation of collagen phagocytosis in aging human fibroblasts: effects of integrin expression and cell cycle. Exp Cell Res 237, 383, 1997.
24. Chen, S., Takanashi, S., Zhang, Q., Xiong, W., Zhu, S., Peters, E.C., et al. Reversine increases the plasticity of lineage-committed mammalian cells. Proc Natl Acad Sci U S A 104, 10482, 2007.
25. Bellows, C.G., Aubin, J.E., and Heersche, J.N.M. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121, 1985, 1987.
26. Birk, R.Z., Abramovitch-Gottlib, L., Margalit, I.. Aviv, M., Forti, E., Geresh, S., et al. Conversion of adipogenic to osteo-genic phenotype using crystalline porous biomatrices of marine origin. Tissue Eng 12, 21, 2006.
27. Sakaguchi, Y., Sekiya, I., Yagishita, K., and Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52, 2521, 2005.
28. Cartmell, S., Huynh, K., Lin, A., Nagaraja, S., and Guldberg. R. Quantitative microcomputed tomography analysis of mineralization within three-dimensional scaffolds in vitro. J Biomed Mater Res A 69, 97, 2004.
29. Mauney, J.R., Jaquiery, C., Volloch, V., Heberer, M., Martin, I., and Kaplan, D.L. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26, 3173, 2005.
30. Kim, Y.K., Choi, H.Y., Kim, N.H., Lee, W., Seo, D.W., Kang, D.W., et al. Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells. Biochem Biophys Res Commun 358, 553, 2007.
31. Kim, S., Rosania, G.R. and Chang, Y.T. Dedifferentiation? what's next? Mol Interv 4, 83, 2004.
32. Simmons, P.J., and Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55, 1991.
33. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97, 13625, 2000.
34. Bensidhoum, M., Chapel, A., Francois, S., Demarquay, C., Mazurier, C., Fouillard, L., et al. Homing of in vitro expanded Stro-1-or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103, 3313, 2004.
35. Stewart, K., Walsh, S., Screen, J., Jefferiss, C.M., Chainey, J., Jordan, G.R., et al. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 14, 1345, 1999.
36. van den Dolder, J., and Jansen, J.A. Enrichment of osteogenic cell populations from rat bone marrow stroma. Biomaterials 28, 249, 2007.
37. Ravasi, T., Wells, C., Forest, A., Underhill, D.M., Wain-wright, B.J., Aderem, A., et al. Generation of diversity in the innate immune system: macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes. J Immunol 168, 44, 2002.
38. Cuetara, B.L., Crotti, T.N., O'Donoghue, A.J., and McHugh, K.P. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim 42, 182, 2006.
39. Hwang, S.G., Yu, S.S., Lee, S.W., Chun, J.S. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. FEBS Lett 579, 4837, 2005.
40. Zhang, X.S., Zhang, Z.H., Guo, S.H., Yang, W., Zhang, Z.Q., Yuan, J.X., et al. Activation of extracellular signal-related kinases 1 and 2 in Sertoli cells in experimentally cryptorchid rhesus monkeys. Asian J Androl 8, 265, 2006.
41. Kaempchen, K., Mielke, K., Utermark, T., Langmesser, S., and Hanemann, C.O. Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum Mol Genet 12, 1211, 2003.
42. Dresske, B., El Mokhtari, N.E., Ungefroren, H., Ruhnke, M., Plate, V., Janssen, D., et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant 6, 947, 2006.
43. Chung, Y.S., Kim, H.J., Kim, T.M., Hong, S.H., Kwon, K.R., An, S., et al. Undifferentiated hematopoietic cells are characterized by a genome-wide undermethylation dip around the transcription start site and a hierarchical epigenetic plasticity. Blood 114, 4968, 2009.
44. Gohel, A., McCarthy, M.B., and Gronowicz, G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140, 5339, 1999.
45. Weinstein, R.S., Chen, J.R., Powers, C.C., Stewart, S.A., Landes, R.D., Bellido, T., et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109, 1041, 2002.
46. Shao, J., Xu, X., Li, G., Zhang, W., Qi, J., Wang, J., et al. Inhibitory effects of pharmacological doses of dexamethasone on mineralization of mesenchymal progenitor cells in vitro. Pharmazie 64, 674, 2009.
47. Walker, G., Pfeilschifter, J., and Kunz, D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem 272, 16679, 1997.
48. Gotoh, T., and Mori, M. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apopto-sis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 144, 427, 1999.
49. Albina, J.E., Cui, S., Mateo, R.B., and Reichner, J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150, 5080, 1993.
50. Taylor, E.L., Megson, I.L., Haslett, C., and Rossi, A.G. Nitric oxide: a key regulator of myeloid inflammatory cell apo-ptosis. Cell Death Differ 10, 418, 2003.
51. Boyan, B.D., Bonewald, L.F., Paschalis, E.P., Lohmann, C.H., Rosser, J., Cochran, D.L., et al. Osteoblast-mediated mineral deposition in culture is dependent on surface micro-topography. Calcif Tissue Int 71, 519, 2002.
52. Bonewald, L.F., Harris, S.E., Rosser, J., Dallas, M.R., Dallas, S.L., Camacho, N.P., et al. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 72, 537, 2003.
53. Collas, P. Dedifferentiation of cells: new approaches. Cyto-therapy 9, 236, 2007.
54. Gey, C., and Giannis, A. Small molecules, big plans\-can low-molecular-weight compounds control human regeneration? Angew Chem Int Ed Engl 43, 3998, 2004.
55. Liu, H.X., Hu, D.H., Jia, C.Y., and Fu, X.B. Progress of cellular dedifferentiation research. Chin J Traumatol 9, 308, 2006.
56. Perreira, M., Jiang, J.K., Klutz, A.M., Gao, Z.G., Shainberg, A., Lu, C., et al. ''Reversine'' and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 48, 4910, 2005.
57. Bogoyevitch, M.A., Boehm, I., Oakley, A., Ketterman, A.J., and Barr, R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 1697, 89, 2004.
58. Wang, Y., Ji, H.X., Xing, S.H., Pei, D.S., and Guan, Q.H. SP600125, a selective JNK inhibitor, protects ischemic renal injury via suppressing the extrinsic pathways of apoptosis. Life Sci 80, 2067, 2007.